The Korean Motherisk Program

Goal:

As a teratogen information center, our goal is to provide up-to-date information on the potential teratogenic effects of therapeutic and illicit drugs, over-the-counter medications, natural products, alcohol, cigarette smoking, and radiation to women of childbearing age who are planning pregnancy, or to pregnant or breastfeeding women, and to their healthcare providers.

Background:

For approximately 10 years, The Korean Motherisk Program has been providing women with preconception and prenatal teratogen-risk counselling. Our service once available only at the clinic, has now been revolutionized by introducing counselling by e-mail and more recently by telephone. In order to fulfill our vision to provide all women with the easiest form of access to our counsellors and databases, we are always in the development of new ways of improving our communication services.

Our Program is also backed by international collaborations which in turn enables us to more effectively acquire experience and expand our knowledge on the use of drugs and medications by pregnant or breastfeeding women.

MotherSafe Counselling Centers

In 2010, we envisioned a unique opportunity to reduce the gap for providing teratogen information to patients living in communities far from Seoul. Our Program extended its services through three MotherSafe Counselling Centers, funded by the Ministry for Health and Welfare.

MotherSafe Line

This is a toll-free information service which provided information about the potential teratogenicity of therapeutic and illicit drugs, alcohol, cigarette smoking, chemicals and other environmental hazards.

Service hours: Monday to Friday between 9:00 a.m. and 5:00 p.m.

☎ : 82-2-1588-7309

Our Staff:

▶ Cheil Hospital, seoul

Jung-Yeol Han MD, PhD Professor, Division of Maternal Fetal medicine, OB&Gyn. Cheil General Hospital, Kwandong University, College of Medicine, Seoul Korea Head of director the Korean Motherisk Program Fellowship(Clinical pharmacology, Toxicology, and Motherisk Progrma) in University of Toronto(2003-2004) International Board of Certified Lactation Consultant(2003~) Member of Organization of Teratology specialist(2008~) Member of Korean Reproductive and Development Toxicology Research Association(2004~)

Jun-Sik Choi MD, PhD Associate professor, Division of Maternal Fetal medicine, OB&Gyn. Cheil General Hospital, Kwandong University, College of Medicine, Seoul Korea Member of Organization of Teratology Specialist Associate director the Korean Motherisk Program Member of Korean Society of Obstetrics and Gynecology Member of Insurance Committee of Korean Society of Obstetrics and Gynecology Member of Special Committee of the Korean Perinatology

Hyun-Kyoung Ahn MD, PhD Associate professor, Division of Maternal Fetal medicine, OB&Gyn. Cheil General Hospital, Kwandong University, College of Medicine, Seoul Korea Associate director the Korean Motherisk Program Fellowship(Clinical Immunology) in University of Rosalindfranklin university (2009-2010) in Chicago, USA International Board of Certified Lactation Consultant(2003~) Member of American society of reproductive immunology

Gye-Jung Yeom The Department of Nursing Science -master’s course Korea motherisk program Consultant Counseling and information

Min-Kyong Choi Korea motherisk program Consultant Management and Administration

Sun-Woo Yun Korea motherisk program Consultant DB Construction and Work support

▶ Ilshin Christian Hospital, Busan

KIM MOON JUNG Busan National University, College of Medicine Ilsin Christian Hospital resident training Specialist of Obstetrics and Gynecology Staff of the Obstetrics and Gynecology, Ilsin Christian Asan Hospital Gynecology research Busan National University gaduate school master degree

LEE SO YOUNG Busan National University, College of Medicine Ilsin Christian Hospital resident training Specialist of Obstetrics and Gynecology Staff of the Obstetrics and Gynecology, Ilsin Christian Hospital

KIM HEE JIN Busan National University, College of Medicine Ilsin Christian Hospital resident training Specialist of Obstetrics and Gynecology Staff of the Obstetrics and Gynecology, Ilsin Christian Hospital

CHOI KYOUNG A Busan National University, College of Medicine Ilsin Christian Hospital resident training Specialist of Obstetrics and Gynecology Staff of the Obstetrics and Gynecology, Ilsin Christian Hospital

▶ Chonnam National University Hospital, Gwangju

Tae-Bok Song, Prof., M.D. Dept. of Ob & Gyn, Chonnam National University Hospital, Korea Vice President, Korean Society of Ultrasound in Obstet & Gynecol director, Korean Society of Menopause, director, Korean Society of Perinatology   1994-1996 : Audit, Korean Society of Perinatology 1995-1996 : Audit, Yunghonam Society of Obstetrics and Gynecology 1997-2000 : Member of Examination Committee, Korean Association of Obstetrics and Gynecology 2000-2002 : Audit, Korean Society of Fetal Medicine 2000-2002 : Chief of Planning Committee, Korean Society of Perinato 2001-2003 : Chief of public information Committee, Korean Society of Ultrasound in Obstet & Gynecol 2002-2004 : Chief of public information Committee, Korean Society of Perinatology 2002-2004 : Chief of Planning Committee, Korean Society of Fetal Medicine 2003-2005 : Vice President, Korean Society of Ultrasound in Obstet & Gynecol 2004-2006 : Chief of Planning Committee, Korean Society of Fetal Medicine 2005-2005 : Chief of Planning Committee, Korean Society of Obstetrics and Gynecology 2005-2007 : Vice President, Korean Society of Ultrasound in Obstet & Gynecol 2005-2007 : Chief of Finance Committee, Korean Society of Obstetrics and Gynecology

Mi-a Jung The Korea Motherisk Program Chonnam National University Hospital Counselor

▶ Miz Women’s Hospital, daejeon

Dal-Soo Hong MD Miz Women’s Hospital, 673 Tan-Bang Dong, SeoGu, Tae-jeon City, Chungnam, S.Korea Fellowship Division of Maternal Fetal medicine( Motherisk Program), OB&Gyn. Cheil General Hospital, Kwandong University, College of Medicine, Seoul Korea (2005-2006) Member of the Korean Motherisk Program

Our publications:

• 1.Lee SW, Han JY, Choi JS, Chung JH, Kim MY, Yang JH, Koong MK, Nava-Ocampo AA, Koren G.
  Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
  Reprod Toxicol. 2009
• 2.Kim MH, Han JY, Cho YJ, Ahn HK, Kim JO, Ryu HM, Kim MY, Yang JH, Nava-Ocampo AA.
  Factors associated with a positive intake of folic acid in the periconceptional period among Korean women.
  Public Health Nutr. 2009
• 3.Levy S, Fayez I, Taguchi N, Han JY, Aiello J, Matsui D, Moretti M, Koren G, Ito S.
  Pregnancy outcome following in utero exposure to bisphosphonates.
  Bone. 2009
• 4.Cho YJ, Han JY, Choi JS, Ahn HK, Ryu HM, Kim MY, Yang JH, Nava-Ocampo AA, Koren G.
  Prenatal multivitamins containing folic acid do not decrease prevalence of depression among pregnant women.
  J Obstet Gynaecol. 2008
• 5.Ahn HK, Choi JS, Han JY, Kim MH, Chung JH, Ryu HM, Kim MY, Yang JH, Koong MK, Nava-Ocampo AA, Koren G.
  Pregnancy outcome after exposure to oral contraceptives during the periconceptional period.
  Hum Exp Toxicol. 2008
• 6. Kim HH, Nava-Ocampo AA, Kim SK, Kim SH, Kim YJ, Han JY, Ahn HK, Ryu HM, Yang JH, Kim MY.
  Is prenatal childbirth preparation effective in decreasing adverse maternal and neonatal response to labor? A nested case-control study.
  Acta Biomed. 2008
• 7. Choi JS, Han JY, Kim MY, Velazquez-Armenta EY, Nava-Ocampo AA.
  Pregnancy outcomes in women using inhaled fluticasone during pregnancy: a case series.
  Kim HH, Nava-Ocampo AA, Kim SK, Kim SH, Kim YJ, Han JY, Ahn HK, Ryu HM, Yang JH, Kim MY.
• 8. Ahn HK, Nava-Ocampo AA, Han JY, Choi JS, Chung JH, Yang JH, Koong MK, Park CT.
  Exposure to amlodipine in the first trimester of pregnancy and during breastfeeding.
  Hypertens Pregnancy. 2007
• 9. Velazquez-Armenta EY, Han JY, Choi JS, Yang KM, Nava-Ocampo AA.
  Angiotensin II receptor blockers in pregnancy: a case report and systematic review of the literature.
  Hypertens Pregnancy. 2007
• 10. June-Seek Choi, MD12, Jung-Yeol Han, MD12, Hyun-Kyong Ahn, MD12, Joong-Sik Shin, MD2, Jae-Hyug Yang, MD2, Mi-Kyoung Koong, MD3 and Alejandro A. Nava-Ocampo, MD4
  Exposure to rosiglitazone and fluoxetine in the first trimester of pregnancy
  Diabetes Care. 2006
• 11. Nava-Ocampo AA, Velazquez-Armenta EY, Han JY, Koren G.
  Use of proton pump inhibitors during pregnancy and breastfeeding.
  Can Fam Physician. 2006
• 12. Ebrahim SH, Lo SS, Zhuo J, Han JY, Delvoye P, Zhu L.
  Models of preconception care implementation in selected countries.
  Matern Child Health J. 2006
• 13. Chun JY, Han JY, Ahn HK, Choi JS, Koong MK, Nava-Ocampo AA, Koren G.
  Fetal outcome following roxithromycin exposure in early pregnancy.
  J Matern Fetal Neonatal Med. 2006
• 14. Han JY, Nava-Ocampo AA.
  Fetal heart rate response to cordocentesis and pregnancy outcome: a prospective cohort.
  J Matern Fetal Neonatal Med. 2005
• 15. Kim JO, Han JY, Choi JS, Ahn HK, Yang JH, Kang IS, Song MJ, Nava-Ocampo AA.
  Oral misoprostol and uterine rupture in the first trimester of pregnancy: a case report.
  Reprod Toxicol. 2005
• 16. Han JY, Nava-Ocampo AA, Koren G.
  Unintended pregnancies and exposure to potential human teratogens
  Birth Defects Res A Clin Mol Teratol. 2005
• 17.Han JY, Nava-Ocampo AA, Kim TJ, Shim JU, Park CT.
  Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors: report of 2 cases.
  Reprod Toxicol. 2005
• 18. Teratogen risk counselling by internet: a prospective cohort study.
  Teratogen risk counselling by internet: a prospective cohort study.
  J Obstet Gynaecol. 2005
• 19.Yang JH, Kim YJ, Chung JH, Kim MY, Ryu HM, Ahn HK, Han JY, Yang SH, Kim A, Kim HS, Lee PJ, Kim SS, Kim YJ, Koh KS, Shin JC, Cho YK, Yoon BH.
  A multi-center study for birth defect monitoring systems in Korea.
  J Korean Med Sci. 2004
• 20. Jung Yeol Han, M.D.
  What is the Mother Safe Program? Background and Tasks
  Korean J Perinatol. 2010
• 21. J.Y.Han, S.Y.Park *, Y.M.Kim *, J.W.Kim *, S.H.Jung, Y.C.Chung, J.S.Choi, H.K.Ahn, M.J.Oh, H.M.Ryu, M.Y.Kim, M.K.Koong, I.S.Kang, K.H.Choi, H.W.Han, J.H.Yang
  Evidence - ba s ed T eratog enic Risk Coun s eling in Pr eg nant Women Ex posed to Medicat ion or Diagn ost ic Radiat ion Durin g the F ir s t T rimes ter
  대한산부회지 2002

Our Address:

1-19 Mookjung-Dong, Jung-Gu, Seoul, Korea 100-380

Telephone : 82-2-2000-7984

E-mail : Koreanmotherisk@yahoo.co.kr

Visit our websites

The Korean Motherisk Program: http://www.motherisk.or.kr

MotherSafe Centers: http://blog.mothersafe.or.kr

보건 복지부 제일 병원 식품의약품안전청 --------------------- The Motherisk Program Otispregnancy Teratology --------------------- 대한 선천성 기형포럼 한국모유수유 협회